aluates Reports

$ 0.0

Automative

Global Adult Chronic Hepatitis B Treatment Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-15A13061

Global Adult Chronic Hepatitis B Treatment Market Research Report 2023

BUY CHAPTERS

Global Adult Chronic Hepatitis B Treatment Market Research Report 2025

Code: QYRE-Auto-15A13061

Report

May 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

ViiV Healthcare

Bristol–Myers Squibb

Gilead Sciences

Accord Healthcare

Teva Pharmaceuticals

Apotex Corp.

CTTQ

Arbutus Biopharma

Lupin Pharmaceuticals

Adult Chronic Hepatitis B Treatment Market Size

The global market for Adult Chronic Hepatitis B Treatment was valued at US$ 3568 million in the year 2024 and is projected to reach a revised size of US$ 4554 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Adult Chronic Hepatitis B Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Adult Chronic Hepatitis B Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult Chronic Hepatitis B Treatment.

The Adult Chronic Hepatitis B Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult Chronic Hepatitis B Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adult Chronic Hepatitis B Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Adult Chronic Hepatitis B Treatment Market Report

Report Metric	Details
Report Name	Adult Chronic Hepatitis B Treatment Market
Accounted market size in year	US$ 3568 million
Forecasted market size in 2031	US$ 4554 million
CAGR	3.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Interferon Antiviral Drugs
Segment by Application	Hospitals Homecare Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, ViiV Healthcare, Bristol-Myers Squibb, Gilead Sciences, Accord Healthcare, Teva Pharmaceuticals, Apotex Corp, CTTQ, Arbutus Biopharma, Lupin Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adult Chronic Hepatitis B Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Adult Chronic Hepatitis B Treatment Market growing?

Ans: The Adult Chronic Hepatitis B Treatment Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Adult Chronic Hepatitis B Treatment Market size in 2031?

Ans: The Adult Chronic Hepatitis B Treatment Market size in 2031 will be US$ 4554 million.

Who are the main players in the Adult Chronic Hepatitis B Treatment Market report?

Ans: The main players in the Adult Chronic Hepatitis B Treatment Market are Novartis, ViiV Healthcare, Bristol-Myers Squibb, Gilead Sciences, Accord Healthcare, Teva Pharmaceuticals, Apotex Corp, CTTQ, Arbutus Biopharma, Lupin Pharmaceuticals

What are the Application segmentation covered in the Adult Chronic Hepatitis B Treatment Market report?

Ans: The Applications covered in the Adult Chronic Hepatitis B Treatment Market report are Hospitals, Homecare, Clinics, Others

What are the Type segmentation covered in the Adult Chronic Hepatitis B Treatment Market report?

Ans: The Types covered in the Adult Chronic Hepatitis B Treatment Market report are Interferon, Antiviral Drugs

Recommended Reports

Hepatitis and Liver

Chronic Disease Treatment

Antiviral and Infection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Interferon

1.2.3 Antiviral Drugs

1.3 Market by Application

1.3.1 Global Adult Chronic Hepatitis B Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Homecare

1.3.4 Clinics

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Adult Chronic Hepatitis B Treatment Market Perspective (2020-2031)

2.2 Global Adult Chronic Hepatitis B Treatment Growth Trends by Region

2.2.1 Global Adult Chronic Hepatitis B Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Adult Chronic Hepatitis B Treatment Historic Market Size by Region (2020-2025)

2.2.3 Adult Chronic Hepatitis B Treatment Forecasted Market Size by Region (2026-2031)

2.3 Adult Chronic Hepatitis B Treatment Market Dynamics

2.3.1 Adult Chronic Hepatitis B Treatment Industry Trends

2.3.2 Adult Chronic Hepatitis B Treatment Market Drivers

2.3.3 Adult Chronic Hepatitis B Treatment Market Challenges

2.3.4 Adult Chronic Hepatitis B Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adult Chronic Hepatitis B Treatment Players by Revenue

3.1.1 Global Top Adult Chronic Hepatitis B Treatment Players by Revenue (2020-2025)

3.1.2 Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Adult Chronic Hepatitis B Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Adult Chronic Hepatitis B Treatment Revenue

3.4 Global Adult Chronic Hepatitis B Treatment Market Concentration Ratio

3.4.1 Global Adult Chronic Hepatitis B Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adult Chronic Hepatitis B Treatment Revenue in 2024

3.5 Global Key Players of Adult Chronic Hepatitis B Treatment Head office and Area Served

3.6 Global Key Players of Adult Chronic Hepatitis B Treatment, Product and Application

3.7 Global Key Players of Adult Chronic Hepatitis B Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Adult Chronic Hepatitis B Treatment Breakdown Data by Type

4.1 Global Adult Chronic Hepatitis B Treatment Historic Market Size by Type (2020-2025)

4.2 Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Type (2026-2031)

5 Adult Chronic Hepatitis B Treatment Breakdown Data by Application

5.1 Global Adult Chronic Hepatitis B Treatment Historic Market Size by Application (2020-2025)

5.2 Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Adult Chronic Hepatitis B Treatment Market Size (2020-2031)

6.2 North America Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025)

6.4 North America Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Adult Chronic Hepatitis B Treatment Market Size (2020-2031)

7.2 Europe Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025)

7.4 Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size (2020-2031)

8.2 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Adult Chronic Hepatitis B Treatment Market Size (2020-2031)

9.2 Latin America Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025)

9.4 Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size (2020-2031)

10.2 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Adult Chronic Hepatitis B Treatment Introduction

11.1.4 Novartis Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 ViiV Healthcare

11.2.1 ViiV Healthcare Company Details

11.2.2 ViiV Healthcare Business Overview

11.2.3 ViiV Healthcare Adult Chronic Hepatitis B Treatment Introduction

11.2.4 ViiV Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.2.5 ViiV Healthcare Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Introduction

11.3.4 Bristol-Myers Squibb Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Adult Chronic Hepatitis B Treatment Introduction

11.4.4 Gilead Sciences Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Accord Healthcare

11.5.1 Accord Healthcare Company Details

11.5.2 Accord Healthcare Business Overview

11.5.3 Accord Healthcare Adult Chronic Hepatitis B Treatment Introduction

11.5.4 Accord Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.5.5 Accord Healthcare Recent Development

11.6 Teva Pharmaceuticals

11.6.1 Teva Pharmaceuticals Company Details

11.6.2 Teva Pharmaceuticals Business Overview

11.6.3 Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Introduction

11.6.4 Teva Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.6.5 Teva Pharmaceuticals Recent Development

11.7 Apotex Corp

11.7.1 Apotex Corp Company Details

11.7.2 Apotex Corp Business Overview

11.7.3 Apotex Corp Adult Chronic Hepatitis B Treatment Introduction

11.7.4 Apotex Corp Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.7.5 Apotex Corp Recent Development

11.8 CTTQ

11.8.1 CTTQ Company Details

11.8.2 CTTQ Business Overview

11.8.3 CTTQ Adult Chronic Hepatitis B Treatment Introduction

11.8.4 CTTQ Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.8.5 CTTQ Recent Development

11.9 Arbutus Biopharma

11.9.1 Arbutus Biopharma Company Details

11.9.2 Arbutus Biopharma Business Overview

11.9.3 Arbutus Biopharma Adult Chronic Hepatitis B Treatment Introduction

11.9.4 Arbutus Biopharma Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.9.5 Arbutus Biopharma Recent Development

11.10 Lupin Pharmaceuticals

11.10.1 Lupin Pharmaceuticals Company Details

11.10.2 Lupin Pharmaceuticals Business Overview

11.10.3 Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Introduction

11.10.4 Lupin Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025)

11.10.5 Lupin Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

ViiV Healthcare

Bristol–Myers Squibb

Gilead Sciences

Accord Healthcare

Teva Pharmaceuticals

Apotex Corp.

CTTQ

Arbutus Biopharma

Lupin Pharmaceuticals

List of Tables

Table 1. Global Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Interferon

Table 3. Key Players of Antiviral Drugs

Table 4. Global Adult Chronic Hepatitis B Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Adult Chronic Hepatitis B Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Adult Chronic Hepatitis B Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Adult Chronic Hepatitis B Treatment Market Share by Region (2020-2025)

Table 8. Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Adult Chronic Hepatitis B Treatment Market Share by Region (2026-2031)

Table 10. Adult Chronic Hepatitis B Treatment Market Trends

Table 11. Adult Chronic Hepatitis B Treatment Market Drivers

Table 12. Adult Chronic Hepatitis B Treatment Market Challenges

Table 13. Adult Chronic Hepatitis B Treatment Market Restraints

Table 14. Global Adult Chronic Hepatitis B Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Adult Chronic Hepatitis B Treatment Market Share by Players (2020-2025)

Table 16. Global Top Adult Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Chronic Hepatitis B Treatment as of 2024)

Table 17. Ranking of Global Top Adult Chronic Hepatitis B Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Adult Chronic Hepatitis B Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Adult Chronic Hepatitis B Treatment, Headquarters and Area Served

Table 20. Global Key Players of Adult Chronic Hepatitis B Treatment, Product and Application

Table 21. Global Key Players of Adult Chronic Hepatitis B Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Adult Chronic Hepatitis B Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Adult Chronic Hepatitis B Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Adult Chronic Hepatitis B Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Adult Chronic Hepatitis B Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Novartis Company Details

Table 47. Novartis Business Overview

Table 48. Novartis Adult Chronic Hepatitis B Treatment Product

Table 49. Novartis Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 50. Novartis Recent Development

Table 51. ViiV Healthcare Company Details

Table 52. ViiV Healthcare Business Overview

Table 53. ViiV Healthcare Adult Chronic Hepatitis B Treatment Product

Table 54. ViiV Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 55. ViiV Healthcare Recent Development

Table 56. Bristol-Myers Squibb Company Details

Table 57. Bristol-Myers Squibb Business Overview

Table 58. Bristol-Myers Squibb Adult Chronic Hepatitis B Treatment Product

Table 59. Bristol-Myers Squibb Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 60. Bristol-Myers Squibb Recent Development

Table 61. Gilead Sciences Company Details

Table 62. Gilead Sciences Business Overview

Table 63. Gilead Sciences Adult Chronic Hepatitis B Treatment Product

Table 64. Gilead Sciences Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 65. Gilead Sciences Recent Development

Table 66. Accord Healthcare Company Details

Table 67. Accord Healthcare Business Overview

Table 68. Accord Healthcare Adult Chronic Hepatitis B Treatment Product

Table 69. Accord Healthcare Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 70. Accord Healthcare Recent Development

Table 71. Teva Pharmaceuticals Company Details

Table 72. Teva Pharmaceuticals Business Overview

Table 73. Teva Pharmaceuticals Adult Chronic Hepatitis B Treatment Product

Table 74. Teva Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 75. Teva Pharmaceuticals Recent Development

Table 76. Apotex Corp Company Details

Table 77. Apotex Corp Business Overview

Table 78. Apotex Corp Adult Chronic Hepatitis B Treatment Product

Table 79. Apotex Corp Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 80. Apotex Corp Recent Development

Table 81. CTTQ Company Details

Table 82. CTTQ Business Overview

Table 83. CTTQ Adult Chronic Hepatitis B Treatment Product

Table 84. CTTQ Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 85. CTTQ Recent Development

Table 86. Arbutus Biopharma Company Details

Table 87. Arbutus Biopharma Business Overview

Table 88. Arbutus Biopharma Adult Chronic Hepatitis B Treatment Product

Table 89. Arbutus Biopharma Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 90. Arbutus Biopharma Recent Development

Table 91. Lupin Pharmaceuticals Company Details

Table 92. Lupin Pharmaceuticals Business Overview

Table 93. Lupin Pharmaceuticals Adult Chronic Hepatitis B Treatment Product

Table 94. Lupin Pharmaceuticals Revenue in Adult Chronic Hepatitis B Treatment Business (2020-2025) & (US$ Million)

Table 95. Lupin Pharmaceuticals Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Adult Chronic Hepatitis B Treatment Picture

Figure 2. Global Adult Chronic Hepatitis B Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Adult Chronic Hepatitis B Treatment Market Share by Type: 2024 VS 2031

Figure 4. Interferon Features

Figure 5. Antiviral Drugs Features

Figure 6. Global Adult Chronic Hepatitis B Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Adult Chronic Hepatitis B Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Homecare Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Adult Chronic Hepatitis B Treatment Report Years Considered

Figure 13. Global Adult Chronic Hepatitis B Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Adult Chronic Hepatitis B Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Adult Chronic Hepatitis B Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Adult Chronic Hepatitis B Treatment Market Share by Players in 2024

Figure 17. Global Top Adult Chronic Hepatitis B Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Chronic Hepatitis B Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Adult Chronic Hepatitis B Treatment Revenue in 2024

Figure 19. North America Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Adult Chronic Hepatitis B Treatment Market Share by Country (2020-2031)

Figure 21. United States Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Adult Chronic Hepatitis B Treatment Market Share by Country (2020-2031)

Figure 25. Germany Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Adult Chronic Hepatitis B Treatment Market Share by Region (2020-2031)

Figure 33. China Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Adult Chronic Hepatitis B Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Adult Chronic Hepatitis B Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Adult Chronic Hepatitis B Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 49. ViiV Healthcare Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 51. Gilead Sciences Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 52. Accord Healthcare Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 53. Teva Pharmaceuticals Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 54. Apotex Corp Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 55. CTTQ Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 56. Arbutus Biopharma Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 57. Lupin Pharmaceuticals Revenue Growth Rate in Adult Chronic Hepatitis B Treatment Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti HBV Drugs Market Research Report 2025

Global Hepatitis Viruses Diagnostic Tests Market Research Report 2024

Liver Cancer Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Liver Diseases Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis C Virus Drugs Market Research Report 2025

Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hepatitis B Diagnostic Tests Market Research Report 2024

Global Still s Disease Treatment Market Research Report 2025

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Liver Cirrhosis Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dengue Fever Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatocellular Carcinoma Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Direct acting Antiviral Drugs Market

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Viral Vector Vaccine for Humans Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z16367

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global PRRS Test Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-31R16467

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Vaccine Separation and Purification Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39K16341

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inactivated Hepatitis A Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36N16760

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions